Roivant Sciences Ltd.
ROIV | NASDAQ
$36.49
-$0.42 (-1.14%)
Nov 2, 2026, 10:40 AM ET · Market open
Fiscal Quarter Period Ending | Q1 2026 Jun 30, 2026 | Q4 2025 Mar 31, 2026 | Q3 2025 Dec 31, 2025 | Q2 2025 Sep 30, 2025 | Q1 2025 Jun 30, 2025 | Q4 2024 Mar 31, 2025 | Q3 2024 Dec 31, 2024 | Q2 2024 Sep 17, 2024 | Q1 2024 Jun 30, 2024 | Q4 2023 Mar 31, 2024 | Q3 2023 Dec 31, 2023 | Q2 2023 Sep 30, 2023 | Q1 2023 Jun 30, 2023 | Q4 2022 Mar 31, 2023 | Q3 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.25B | 1.42B | 1.48B | 1.24B | 1.24B | 2.72B | 1.99B | 1.96B | 5.68B | 6.54B | 6.67B | 1.41B | 1.44B | 1.68B | 1.53B |
Short-Term Investments | 2.59B | 2.87B | 3.05B | 3.15B | 3.26B | 2.17B | 3.16B | 3.43B | n/a | 5.37M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 444.62M | 415.88M | 433.91M | 412.32M | 283.81M | 302.94M | 290.04M | 311.35M | 272.36M | 247.75M | 239.93M | 259.88M | 306.53M | 314.61M | 282.1M |
Other Long-Term Assets | 29.59M | 33.02M | 34.56M | 27.83M | 31.09M | 32.86M | 33.88M | 36.9M | 23.43M | 39.11M | 46.85M | 40.31M | 36.02M | 39.19M | 36.59M |
Receivables | 793.23M | 789.84M | n/a | n/a | n/a | n/a | 143.78M | 22.68M | 215.22M | 82.81M | 63.19M | 54.62M | 39.91M | 32.74M | 29.45M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34M | 35.25M | 5.24M | 4.91M | 4.23M | 2.76M | n/a |
Other Current Assets | 106.77M | 81.86M | 129.91M | 125.81M | 112.6M | 113.17M | 16.02M | 336.94M | 11.08M | 17.6M | 14.85M | 17.68M | 13M | 20.44M | 15.87M |
Total Current Assets | 4.74B | 5.17B | 4.66B | 4.51B | 4.62B | 5B | 5.36B | 5.8B | 6B | 6.73B | 6.81B | 1.55B | 1.56B | 1.8B | 1.65B |
Property-Plant & Equipment | 90.21M | 92.4M | 97.01M | 110.8M | 101.94M | 101.08M | 104.46M | 56.65M | 63.15M | 65.95M | 68.76M | 73.11M | 87.9M | 92.34M | 91.93M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 136.01M | 137.84M | 150.42M | 140.62M | 145.04M | 144.88M | 146.11M |
Total Long-Term Assets | 564.41M | 560.66M | 565.48M | 550.95M | 416.85M | 436.88M | 428.38M | 404.91M | 494.95M | 490.65M | 505.95M | 513.92M | 575.49M | 591.02M | 556.73M |
Total Assets | 5.31B | 5.73B | 5.23B | 5.06B | 5.03B | 5.44B | 5.79B | 6.21B | 6.5B | 7.22B | 7.31B | 2.07B | 2.14B | 2.39B | 2.2B |
Account Payables | 25.08M | 18M | 13.29M | 15.06M | 11.55M | 23.69M | 23.71M | 25.13M | 27.74M | 53.23M | 35.23M | 44.12M | 50.04M | 37.83M | 48M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 1.17M | 3.04M | 3.41M | 2.66M | 4.17M | 4.7M | 5.8M | 10.57M | 12.44M | 7.8M |
Short-Term Debt | n/a | 11.15M | 10.44M | n/a | n/a | 9.84M | n/a | n/a | 21.49M | 12M | 45.71M | 59.9M | 55.75M | 54.5M | 49.59M |
Other Current Liabilities | 44.03M | 119.08M | 121.07M | 27.84M | 30.72M | 53.93M | 39.28M | 440.16M | 101.88M | 85.94M | 59.64M | 123.64M | 107.48M | 111.94M | 91.32M |
Total Current Liabilities | 283.6M | 281.24M | 151.96M | 133.86M | 113.87M | 149.41M | 141.48M | 556.25M | 215.05M | 266.76M | 244.9M | 265.55M | 245M | 272.45M | 244.26M |
Long-Term Debt | n/a | n/a | 98.5M | n/a | n/a | n/a | n/a | n/a | 311.72M | 430.59M | 403.34M | 389.45M | 385.07M | 375.52M | 375.12M |
Other Long-Term Liabilities | 6.25M | 38.74M | -97.83M | 33.44M | 12.54M | 10M | 24.41M | 26.55M | 28.55M | 29.34M | 32.8M | 36.29M | 120.62M | 77M | 101.52M |
Total Long-Term Liabilities | 101.02M | 154.39M | 99.18M | 123.28M | 102.83M | 100.33M | 114.89M | 69.74M | 386.12M | 507.2M | 483.2M | 474.36M | 557.5M | 509.57M | 531.57M |
Total Liabilities | 384.62M | 435.63M | 251.14M | 257.14M | 216.7M | 249.74M | 256.38M | 625.99M | 601.16M | 773.95M | 728.1M | 739.91M | 802.51M | 782.02M | 775.82M |
Total Debt | 107.15M | 107.44M | 207.44M | 98.85M | 99.69M | 100.17M | 100.31M | 52.71M | 379.06M | 499.75M | 506.58M | 497.98M | 492.64M | 487.07M | 479.64M |
Book Value | 4.92B | 5.29B | 4.97B | 4.81B | 4.82B | 5.19B | 5.54B | 5.58B | 5.9B | 6.45B | 6.58B | 1.33B | 1.33B | 1.61B | 1.43B |
Book Value Per Share | 6.83 | 6.52 | 7.14 | 7.06 | 7.08 | 7.33 | 7.66 | 7.59 | 7.54 | 8.03 | 7.80 | 1.72 | 1.76 | 2.16 | 2 |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -900.35M | -501.81M | -695M | -429.11M | -315.59M | 116.06M | 460.4M | 395.58M | 671.47M | 576.17M | 727.29M | -4.37B | -4.06B | -3.77B | -3.74B |
Comprehensive Income | 701K | 4.36M | 20.61M | 19.56M | 17.14M | 9.44M | 8.06M | -18.04M | -17.95M | -4.08M | -27.78M | -3.07M | -6.61M | -2.62M | -729K |
Shareholders Equity | 4.23B | 4.53B | 4.27B | 4.36B | 4.35B | 4.69B | 5.19B | 5.15B | 5.44B | 5.97B | 6.09B | 948.53M | 910.73M | 1.16B | 955.52M |
Total Investments | 3.04B | 3.29B | 3.49B | 3.56B | 3.55B | 2.47B | 3.45B | 3.74B | 272.36M | 253.12M | 239.93M | 259.88M | 306.53M | 314.61M | 282.1M |
Add to Watchlist
Select watchlists to add or remove ROIV